IRBM operates within a proprietary R&D facility of 70.000 m² located in Pomezia, just south of Rome.  The Institute is supported by continuous investments to maintain the highest technological standards including chemistry and biology research laboratories, a GMP certified adenoviral vector production area, a modern LAR, fully equipped conference rooms and a large auditorium.

IRBM’s team of over 180 scientists operates in a technologically advanced state-of-the-art infrastructure covering specialties including molecular and cellular biology, biochemistry, pharmacology, medicinal chemistry and computational chemistry.